Bajaj Healthcare Expands Manufacturing Footprint with Genrx Pharmaceuticals Acquisition for X10.85 Crore

Bajaj Healthcare Limited has successfully acquired Genrx Pharmaceuticals Private Limited (in Liquidation) as a going concern, as per the Sale Certificate dated April 4, 2025, issued by the Official Liquidator. The acquisition, valued at X10.85 crore, involves 100% control of the target entity and is expected to be completed within 3—6 months, subject to requisite FDA and other regulatory approvals. Genrx Pharmaceuticals Private Limited, established in 2009, is a WHO-GMP certified pharmaceutical manufacturer that produces allopathic formulations, nutraceuticals, and natural products. The company operates a manufacturing facility located at MIDC Sinnar, Nashik, with the capability to produce solid and semi-solid dosage forms such as tablets, capsules, external preparations, cosmetic products, and nasal sprays.